Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men. (Q51766475)

11 April 2018

title

Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men. (English)

1 reference

11 April 2018

Erratum: Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men

corrigendum / erratum

0 references

L Strandberg

2

0 references

Niklas Andersson

object named as

N Andersson

1

0 references

Claes Ohlsson

object named as

C Ohlsson

8

0 references

Mattias Lorentzon

7

object named as

M Lorentzon

1 reference

11 April 2018

3

S Nilsson

1 reference

11 April 2018

author name string

O Ljungren

4

1 reference

11 April 2018

D Mellström

6

1 reference

11 April 2018

J-O Jansson

9

1 reference

11 April 2018

M K Karlsson

5

1 reference

11 April 2018

language of work or name

English

0 references

publication date

17 March 2009

1 reference

11 April 2018

International Journal of Obesity

published in

1 reference

11 April 2018

volume

33

1 reference

11 April 2018

page(s)

525-533

1 reference

11 April 2018

issue

5

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1038/ijo.2009.47

exact match

0 references

cites work

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

The balance between IL-1 and IL-1Ra in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Blocking IL-1 in systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

IL6 and IL1B Polymorphisms are Associated With Fat Mass in Older Men: The MrOS Study Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Highly parallel SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Cytokines and beta-cell biology: from concept to clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Central interleukin-1 (IL1) signaling is required for pharmacological, but not physiological, effects of leptin on energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Leptin actions on food intake and body temperature are mediated by IL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Role of hypothalamic interleukin-1beta (IL-1beta) in regulation of energy homeostasis by melanocortins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Regulation of central melanocortin signaling by interleukin-1 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1beta-induced hypothalamic pituitary adrenal axis responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Combined Interleukin-6 and Interleukin-1 Deficiency Causes Obesity in Young Mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Age of Attainment of Peak Bone Mass Is Site Specific in Swedish Men-The GOOD Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Polymorphism of interleukin-1 receptor antagonist gene and obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.47

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.47

1 reference

11 April 2018

Dimensions Publication ID

0 references

1 reference

11 April 2018